Name: Biofargo mMODM Mouse Mesenchymal Stem Cell Osteogenic Differentiation Medium
Brand: Biofargo
SKU: BFMMODM100

Description

During mouse mesenchymal stem cell (MSC) osteogenic differentiation studies, inconsistent induction efficiency, variable mineralization levels, and differences between experimental batches can affect downstream analysis of osteoblast formation and bone-related biological mechanisms.

Biofargo mMODM Mouse Mesenchymal Stem Cell Osteogenic Differentiation Medium is a complete osteogenic differentiation medium developed for inducing mouse MSC osteogenesis and supporting reliable osteoblast differentiation research. The optimized formulation provides essential nutrients, amino acids, vitamins, hormones, growth factors, trace minerals and low concentrations of fetal bovine serum to support the transition of mouse MSCs toward osteogenic lineage.

This mouse MSC osteogenic differentiation medium is designed for researchers performing in vitro osteogenesis induction, mineralization evaluation and stem cell differentiation studies. Biofargo mMODM supports commonly used osteogenic assessment workflows including calcium deposition analysis and Alizarin Red staining.

Specifications

Product Name	Biofargo mMODM Mouse MSC Osteogenic Differentiation Medium
Product Type	Mouse mesenchymal stem cell osteogenic differentiation medium
Application	Mouse MSC osteogenesis induction and osteoblast differentiation research
Specification	100 mL
pH	7.1–7.3
Endotoxin	≤0.25 EU/mL
Bacteria/Fungi	Negative
Mycoplasma	Negative
Osmolality	280–320 mOsm/kg·H₂O
Appearance	Pink clear solution
Storage	-20°C, protected from light
Shelf Life	12 months
Research Use	For research use only

Features

Optimized mouse MSC osteogenic differentiation medium for in vitro osteogenesis induction.
Supports mouse mesenchymal stem cell differentiation toward osteoblast lineage.
Contains essential and non-essential amino acids, vitamins, hormones, growth factors and trace minerals.
Includes low concentration fetal bovine serum to support osteogenic differentiation performance.
Suitable for mouse BMSC and mouse MSC osteogenesis research workflows.
Designed for mineralization analysis and calcium deposition studies.
Compatible with Alizarin Red staining-based osteogenic differentiation evaluation.

Performance Data

Mouse MSC Osteogenic Differentiation Morphology

Mouse mesenchymal stem cells were cultured in Biofargo mMODM under osteogenic induction conditions. Morphological changes were monitored during differentiation, with representative osteogenic differentiation results observed after induction.

Mineralization Detection by Alizarin Red Staining

Following osteogenic induction, mineralized extracellular matrix formation was evaluated using Alizarin Red staining, demonstrating calcium deposition associated with osteogenic differentiation.

Alizarin Red staining analysis of mouse MSC osteogenic differentiation using Biofargo mMODM medium

Applications

Biofargo mMODM Mouse MSC Osteogenic Differentiation Medium is designed for researchers studying mouse mesenchymal stem cell osteogenesis, osteoblast differentiation and bone-related biological processes. The optimized formulation supports in vitro osteogenic induction workflows requiring consistent differentiation performance and mineralization evaluation.

Mouse MSC osteogenic differentiation research — Supports induction of mouse mesenchymal stem cells toward osteogenic lineage for stem cell biology studies.
Mouse BMSC osteogenesis studies — Suitable for mouse bone marrow mesenchymal stem cell differentiation experiments and bone formation research.
Osteoblast differentiation analysis — Enables evaluation of MSC transition into osteoblast-like cells during osteogenic induction.
Mineralization assay workflows — Supports calcium deposition and extracellular matrix mineralization analysis after osteogenic induction.
Alizarin Red staining analysis — Compatible with calcium-rich mineralized nodule detection commonly used in osteogenesis research.
Stem cell differentiation studies — Suitable for investigating factors affecting mouse MSC lineage commitment and osteogenic potential.
Bone tissue engineering research — Applicable for in vitro models investigating osteogenic development and bone-related mechanisms.
Drug screening and pathway studies — Supports research evaluating compounds or signaling pathways involved in osteoblast formation.

Recommended Osteogenic Differentiation Workflow

Biofargo mMODM provides a ready-to-use osteogenic induction environment for mouse MSC differentiation experiments. Researchers can initiate osteogenic differentiation after cells reach the appropriate growth stage and monitor morphological changes, mineralized matrix formation and calcium deposition during the induction period.

A typical workflow includes cell preparation, osteogenic induction culture, medium replacement every 2–3 days, morphological observation and endpoint analysis based on mineralization development.

Why Choose Biofargo mMODM?

Mouse MSC differentiation experiments often require optimized induction conditions to achieve reproducible osteogenic outcomes. Variations in basal media components, differentiation supplements and cell conditions may influence osteoblast formation efficiency and mineralization results.

Biofargo mMODM Mouse MSC Osteogenic Differentiation Medium provides a complete osteogenic differentiation formulation designed specifically for mouse mesenchymal stem cell osteogenesis research. By combining essential nutrients, differentiation-supporting components and quality-controlled manufacturing processes, Biofargo mMODM helps researchers establish consistent osteogenic induction workflows.

Compared with preparing individual osteogenic induction supplements separately, Biofargo mMODM reduces preparation complexity and provides a standardized solution for mouse MSC osteogenic differentiation, calcium deposition evaluation and Alizarin Red staining applications.

Experimental Considerations

Seed mouse MSCs at the recommended density and allow cells to reach approximately 70–80% confluence before initiating osteogenic induction.
Maintain cultures at 37°C with 5% CO₂ during osteogenic differentiation.
Replace differentiation medium every 2–3 days during the induction period.
The differentiation period is generally approximately 14–21 days depending on cell source and experimental requirements.
The product does not contain penicillin or streptomycin. Additional antibiotics may be added according to experimental requirements.

FAQ

What is Biofargo mMODM Mouse MSC Osteogenic Differentiation Medium used for?

Biofargo mMODM is a mouse mesenchymal stem cell osteogenic differentiation medium designed for inducing osteogenesis, supporting osteoblast differentiation and evaluating mineralization during mouse MSC culture experiments.

Can Biofargo mMODM be used for mouse BMSC osteogenic differentiation?

Yes. Biofargo mMODM is optimized for mouse MSC osteogenic induction workflows and can be used for mouse bone marrow mesenchymal stem cell differentiation research.

How long does mouse MSC osteogenic differentiation typically require with Biofargo mMODM?

Mouse MSC osteogenic differentiation is typically performed for approximately 14–21 days. The endpoint should be determined based on cell morphology, calcium deposition and mineralized nodule formation.

Which staining methods can be used after Biofargo mMODM osteogenic induction?

Biofargo mMODM-induced osteogenic differentiation can be evaluated using commonly used mineralization detection methods such as Alizarin Red staining for calcium deposition analysis.

Does Biofargo mMODM support osteoblast differentiation research?

Yes. Biofargo mMODM is designed to support mouse MSC differentiation toward osteogenic lineage and is suitable for osteoblast differentiation research applications.

What cells are suitable for Biofargo mMODM?

Biofargo mMODM is designed for mouse mesenchymal stem cell research applications, including mouse MSC and mouse BMSC osteogenic differentiation studies.

What quality control tests are performed for Biofargo mMODM?

Biofargo mMODM is tested for endotoxin level, bacterial/fungal contamination and mycoplasma contamination to support reliable cell culture applications.

How should Biofargo mMODM be stored?

Biofargo mMODM should be stored at -20°C and protected from light. The recommended shelf life is 12 months under proper storage conditions.

Does Biofargo mMODM contain antibiotics?

No. Biofargo mMODM does not contain penicillin or streptomycin. Antibiotics can be added separately if required by the experimental design.

mMODM – Mouse/Rat MSC Osteogenic Differentiation Medium